Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Radiation Therapy for Advanced Hodgkin Lymphoma

Leuk Lymphoma; ePub 2016 Jun 24; Son, Chiu, et al

Publish date:: June 29, 2016

Radiation therapy improves survival in stage III to IV Hodgkin lymphoma, yet it was used increasingly less over a 23-year period ending in 2011, according to a study involving nearly 10,000 individuals.

Investigators analyzed data from the SEER registry. Among their findings:

• Radiation use declined to 16% in 2011 from 25% in 1988.

• 5-year overall survival for stage III and IV patients who received no radiation therapy was 79%, vs 88% in those who did.

• Among people diagnosed after 2000, those who received radiation therapy experienced better overall survival vs those who were not treated with radiation.

Citation: Son C, Chiu B, Koshy M. Patterns of care and survival outcomes examining radiation therapy for advanced Hodgkin lymphoma. [Published online ahead of print June 24, 2016]. Leuk Lymphoma. doi:10.1080/10428194.2016.1193856.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

PDAC: Tumor reduction after neoadjuvant therapy may predict postsurgical survival,

Mortality risks rise with age, infections, but not inhibitor status in persons with non-severe hemophilia A,

‘Impressive’ local control with MRI-guided brachytherapy in cervical cancer,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Must Reads in Aggressive Lymphomas

Study Halted; ‘Hyperprogression’ Seen With Nivolumab for R/R PTCL,

CAR T-Cell Therapy Found Safe, Effective For HIV-Associated Lymphoma,

Bispecific CAR T-cell Therapy Yields Complete Responses in Relapsed/Refractory non-Hodgkin Lymphomas,

5F9 Plus Rituximab Take a Bite Out of Drug-Resistant NHL,

‘Encouraging’ Responses Seen With Durvalumab Plus R-CHOP in DLBCL,